ATE509942T1 - Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren - Google Patents

Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren

Info

Publication number
ATE509942T1
ATE509942T1 AT06841778T AT06841778T ATE509942T1 AT E509942 T1 ATE509942 T1 AT E509942T1 AT 06841778 T AT06841778 T AT 06841778T AT 06841778 T AT06841778 T AT 06841778T AT E509942 T1 ATE509942 T1 AT E509942T1
Authority
AT
Austria
Prior art keywords
oligopeptides
hiv
inhibit
hexapeptides
glycoprotein
Prior art date
Application number
AT06841778T
Other languages
English (en)
Inventor
Escandan Jose Luis Nieva
Elena Maria Jose Gamara
Nogales Maier Lorizate
Arrayago Nerea Huarte
Munaz Ismael Mingarro
Paya Enrique Perez
Original Assignee
Univ Pais Vasco
Univ Valencia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pais Vasco, Univ Valencia filed Critical Univ Pais Vasco
Application granted granted Critical
Publication of ATE509942T1 publication Critical patent/ATE509942T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06841778T 2005-12-30 2006-12-29 Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren ATE509942T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503259A ES2325644B1 (es) 2005-12-30 2005-12-30 Hexapeptidos no proteolizables inhibidores de la glicoproteina 41 del virus del sida.
PCT/ES2006/000726 WO2007077278A1 (es) 2005-12-30 2006-12-29 Oligopeptidos no proteolizables inhibidores dela glicoproteina gp41 del virus del sida

Publications (1)

Publication Number Publication Date
ATE509942T1 true ATE509942T1 (de) 2011-06-15

Family

ID=38227939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06841778T ATE509942T1 (de) 2005-12-30 2006-12-29 Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren

Country Status (5)

Country Link
US (1) US8110545B2 (de)
EP (1) EP1970379B1 (de)
AT (1) ATE509942T1 (de)
ES (2) ES2325644B1 (de)
WO (1) WO2007077278A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
CA2543257C (en) 2003-10-24 2013-12-31 Gencia Corporation Methods and compositions for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
EP3530282A1 (de) * 2018-02-27 2019-08-28 Diaccurate Therapeutische verfahren

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910131A (en) * 1987-12-23 1990-03-20 Mellman Ira S Idiotype and anti-idiotype antibodies useful in virus detection
EP0408663A4 (en) * 1988-04-07 1992-04-08 Univ Alabama Peptides inhibitors of hiv induced cell fusions and syncytia formation
FR2767831B1 (fr) * 1997-09-02 2001-04-13 Agronomique Inst Nat Rech Mecanismes de resistance aux bacteriophages r/m de type ic de bacteries lactiques
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
EA200401611A1 (ru) * 2002-06-10 2005-12-29 Майметикс Корпорейшн Пептиды gp41 и способы ингибирования слияния вич с клетками-мишенями на их основе
US7241803B2 (en) 2002-11-21 2007-07-10 New York Blood Center Compounds for inhibition of HIV infection by blocking HIV entry
EP1701969B1 (de) 2003-12-31 2007-10-24 F.Hoffmann-La Roche Ag Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
EP1701970A2 (de) 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Verfahren zur wiedergewinnung eines gespaltenen peptides von einem träger
ES2315729T3 (es) 2003-12-31 2009-04-01 F. Hoffmann-La Roche Ag Procedimiento y sistemas para la recuperacion de peptidos.

Also Published As

Publication number Publication date
EP1970379B1 (de) 2011-05-18
US8110545B2 (en) 2012-02-07
EP1970379A1 (de) 2008-09-17
US20100197606A1 (en) 2010-08-05
ES2325644B1 (es) 2010-06-28
ES2366579T3 (es) 2011-10-21
ES2325644A1 (es) 2009-09-10
WO2007077278A1 (es) 2007-07-12

Similar Documents

Publication Publication Date Title
ATE509942T1 (de) Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren
WO2007013047A3 (en) Water-dispersible anti-retroviral pharmaceutical compositions
HK1068918A1 (en) A soluble complex comprising a retroviral surface glycoprotein
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
WO2008118849A3 (en) Hiv-1 protease inhibitors
CY1112632T1 (el) Αναστολεις ασπαρτυλ πρωτεασης
ATE445411T1 (de) Mva-exprimierende modifizierte hiv-envelope-, gag-und pol-gene
DE69624346D1 (de) Verbindung der struktur aminosäure-hydroxyethylamino-sulfonamide als inhibitoren der retroviralen protease
WO1999065870A3 (en) Sulfonamide inhibitors of aspartyl protease
EP2319860A3 (de) Rekombinante MVA-Viren, Clade-A/G-, Clade-B- und Clade-C-modifizierte HIV env, gag- und pol-Gene exprimierend
DE60024419D1 (en) Aspartyl-protease-inhibitoren
WO2005076001A3 (en) A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
EP2567967A3 (de) Verwendung von adenoviralen Vektoren zur Erzeugung einer Immunantwort
WO2010041241A3 (en) Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding
KR100725637B1 (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein
WO2007002172A3 (en) Hiv-1 protease inhibitors
ATE374208T1 (de) Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung
JP2002508338A5 (de)
EA200500533A1 (ru) Пептидные производные - ингибиторы слияния при вич-инфекции
WO2005047476A3 (en) Inhibition of retroviral replication through modulation of the host cell ubiquitylation
WO2006030323A3 (en) Compounds that inhibit replication of human immunodeficiency virus
WO2004108886A3 (en) Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein
WO2002034909A3 (en) Engineered chimera of hiv protein fragments and uses thereof
WO2006052820A3 (en) Human immunodeficiency virus vaccine
TH82347B (th) วัคซีนเชื้อไวรัสทางภูมิคุ้มกันบกพร่องของมนุษย์

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties